Biggest News Aggregation in the World
📰 Crossover Management News

Page 2 - Crossover Management News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Crossover Management. Real-time updates on events, politics, business and more.

Cogent Biosciences, Inc. (NASDAQ:COGT) Short Interest Up 6.2% in March

Cogent Biosciences, Inc. (NASDAQ:COGT – Get Free Report) was the target of a significant increase in short interest in the month of March. As of March 15th, there was short interest totalling 9,630,000 shares, an increase of 6.2% from the February 29th total of 9,070,000 shares. Based on an average trading volume of 2,160,000 shares, […]
Leerink Partnrs Robertw Baird Cogent Biosciences Inc Cogent Biosciences Company Profile Crossover Management Jpmorgan Chase Co

Aerovate Therapeutics (NASDAQ:AVTE) Reaches New 12-Month High at $28.39

Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) reached a new 52-week high on Monday . The company traded as high as $28.39 and last traded at $27.85, with a volume of 25873 shares trading hands. The stock had previously closed at $25.78. Analysts Set New Price Targets AVTE has been the subject of several […]
United States Marinus Verwijs Georgea Eldridge Crossover Management Wells Fargo Company Securities Exchange Commission
Source: wkrb13.com

Cogent Biosciences' (COGT) "Neutral" Rating Reiterated at Robert W. Baird

Robert W. Baird reiterated their neutral rating on shares of Cogent Biosciences (NASDAQ:COGT – Free Report) in a research note issued to investors on Monday morning, Marketbeat.com reports. They currently have a $8.00 target price on the technology company’s stock, down from their prior target price of $14.00. Other analysts also recently issued reports about […]
Robertw Baird Blackrock Inc Jpmorgan Chase Co Crossover Management Cogent Biosciences Inc Needham Company
Source: wkrb13.com

Needham & Company LLC Reaffirms Buy Rating for Cogent Biosciences (NASDAQ:COGT)

Needham & Company LLC reissued their buy rating on shares of Cogent Biosciences (NASDAQ:COGT – Free Report) in a research note published on Monday, Benzinga reports. Needham & Company LLC currently has a $18.00 price objective on the technology company’s stock. Several other research firms also recently commented on COGT. JPMorgan Chase & Co. began […]
Robertw Baird Blackrock Inc Jpmorgan Chase Co Cogent Biosciences Inc Crossover Management Needham Company

Cogent Biosciences (NASDAQ:COGT) Shares Pass Below 50-Day Moving Average of $5.87

Shares of Cogent Biosciences, Inc. (NASDAQ:COGT – Get Free Report) passed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $5.87 and traded as low as $4.30. Cogent Biosciences shares last traded at $4.38, with a volume of 1,172,921 shares traded. Analysts Set New Price Targets […]
Marshall Wace Cogent Biosciences Inc Crossover Management Jpmorgan Chase Co Needham Company Cogent Biosciences

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Cogent Biosciences (NASDAQ:COGT) Share Price Crosses Below 50 Day Moving Average of $5.87

Cogent Biosciences, Inc. (NASDAQ:COGT – Get Free Report) passed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $5.87 and traded as low as $4.30. Cogent Biosciences shares last traded at $4.38, with a volume of 1,172,921 shares. Wall Street Analyst Weigh In Several […]
Cogent Biosciences Inc Needham Company Jpmorgan Chase Co Cogent Biosciences Company Profile Crossover Management Blackrock Inc

Aerovate Therapeutics (NASDAQ:AVTE) Trading Down 3.8%

Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) fell 3.8% during mid-day trading on Wednesday . The company traded as low as $19.46 and last traded at $19.50. 6,948 shares were traded during trading, a decline of 86% from the average session volume of 50,843 shares. The stock had previously closed at $20.26. Analyst Upgrades […]
United States Benjamint Dake Citadel Advisors Wells Fargo Company Driehaus Capital Management Securities Exchange Commission

Aerovate Therapeutics (NASDAQ:AVTE) Trading Down 5%

Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) shares were down 5% on Friday . The company traded as low as $19.20 and last traded at $19.27. Approximately 1,629 shares were traded during mid-day trading, a decline of 96% from the average daily volume of 38,733 shares. The stock had previously closed at $20.29. Wall […]
United States Benjamint Dake Wells Fargo Company Aerovate Therapeutics Company Profile Aerovate Therapeutics Inc Highvista Strategies

Icosavax, Inc. (NASDAQ:ICVX) CEO Adam K. Simpson Sells 90,000 Shares

Icosavax, Inc. (NASDAQ:ICVX – Get Free Report) CEO Adam K. Simpson sold 90,000 shares of the firm’s stock in a transaction on Thursday, December 21st. The stock was sold at an average price of $15.44, for a total transaction of $1,389,600.00. Following the transaction, the chief executive officer now directly owns 260,641 shares of the […]
United States Adamk Simpson William Blair Securities Exchange Commission Raymond James Financial Services Advisors Inc Icosavax Company Profile

Thomas Joseph Russo Sells 15,183 Shares of Icosavax, Inc. (NASDAQ:ICVX) Stock

Icosavax, Inc. (NASDAQ:ICVX – Get Free Report) CFO Thomas Joseph Russo sold 15,183 shares of the company’s stock in a transaction dated Wednesday, December 20th. The shares were sold at an average price of $15.46, for a total transaction of $234,729.18. Following the sale, the chief financial officer now owns 38,037 shares in the company, […]
Thomas Joseph Russo William Blair Icosavax Inc Crossover Management Vanguard Group Inc T Rowe Price Investment Management Inc

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science